Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1Farmak, a,s
02 1USV Private Limited
03 1Apicore Pharmaceuticals Private Limited
04 1Curia Missouri, Inc.
05 1MSN Life Sciences Private Limited
06 1Optimus Drugs Private Limited
07 1ScinoPharm Taiwan Ltd.
08 1Sionc Pharmaceutical Private Limited
01 2REGADENOSON
02 1REGADENOSON MONOHYDRATE
03 4Regadenoson
04 1Regadenoson Anhydrous
01 1Czech Republic
02 5India
03 1Taiwan
04 1U.S.A
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1068
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0220
Start Marketing Date : 2019-12-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-229
Start Marketing Date : 2017-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17180-0203
Start Marketing Date : 2008-04-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 69766-103
Start Marketing Date : 2021-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59285-029
Start Marketing Date : 2020-05-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1331
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0024
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
10
PharmaCompass offers a list of Regadenoson Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier.
PharmaCompass also assists you with knowing the Regadenoson Monohydrate API Price utilized in the formulation of products. Regadenoson Monohydrate API Price is not always fixed or binding as the Regadenoson Monohydrate Price is obtained through a variety of data sources. The Regadenoson Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Regadenoson anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regadenoson anhydrous, including repackagers and relabelers. The FDA regulates Regadenoson anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regadenoson anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Regadenoson anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Regadenoson anhydrous supplier is an individual or a company that provides Regadenoson anhydrous active pharmaceutical ingredient (API) or Regadenoson anhydrous finished formulations upon request. The Regadenoson anhydrous suppliers may include Regadenoson anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Regadenoson anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Regadenoson anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Regadenoson anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Regadenoson anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Regadenoson anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Regadenoson anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Regadenoson anhydrous suppliers with NDC on PharmaCompass.
We have 8 companies offering Regadenoson anhydrous
Get in contact with the supplier of your choice:
